AdhereHealth Launches COVID-19 Adherence Solution

Technology Company Expands Medication Adherence Platform to Help Protect High-Risk Populations and Reduce Unnecessary Hospitalizations During Pandemic


Nashville, Tenn. – (May 5, 2020) AdhereHealth today announced the immediate availability of its new COVID-19 Adherence Solution, an innovative program that combines comprehensive predictive analytics and tech-enabled consumer outreach with home-delivered pharmacy services to support the coronavirus crisis response.

COVID-19 has exacerbated existing social determinants of health (SDOH) issues and medication adherence challenges for underserved populations. Statistics show almost 90% of those who are hospitalized with the virus have underlying conditions, and a majority are over the age of 50.

“There’s real-world evidence that shows medication non-adherence is driving more COVID-19 hospitalizations,” said Jason Z. Rose, CEO of AdhereHealth. “By proactively targeting high-risk populations we can help keep more consumers adherent and healthy, and reduce the risk of becoming seriously ill from the virus.”

The COVID-19 Adherence Solution program helps improve health outcomes for at-risk populations by enabling health plans and employers with:

  • Comprehensive predictive analytics to identify populations at higher risk of medication non-adherence
  • Support from a team of nationwide employed licensed clinicians who provide direct omni-channel consumer and provider engagement to discuss health status and coordinate care
  • Data-driven outreach designed to resolve SDOH issues in the context of COVID-19 using available health plan benefits and community resources
  • Private-couriered medication delivery services catering to vulnerable populations

“In normal times, a staggering 50% of patients that are managing chronic conditions don’t take their medications as directed. Factor in continued lockdowns, social distancing and economic hardships, and it’s easy to see how non-adherence is likely to get worse,” said Rose. “Engaging with consumers proactively gives us a chance to get them support before they wind up in a hospital bed.”

About AdhereHealth™
AdhereHealth is a healthcare technology solutions leader supporting health plans, self-insured employers, and other risk-bearing entities for medication adherence insights and improved healthcare outcomes. The company’s Adhere™ platform touches nearly 30 million consumers through advanced technologies and at-risk engagement services. AdhereHealth’s subsidiary company, AdhereRx, is a pharmacy for complex patients with high-risk chronic conditions and social determinants of health issues. AdhereRx coordinates complex medication regimens with providers, performs monthly comprehensive medication reviews (CMR) and drug utilization reviews (DUR), has 24/7 access to pharmacy clinicians, delivers prescriptions via a private courier service, supports those in need of financial assistance, and can take cash on delivery at the consumer’s home. This integrated set of solutions addresses an estimated half a trillion dollars of unnecessary annual medical costs attributed to medication adherence issues. The company is headquartered in the Nashville suburb of Franklin, Tennessee. For more information, please visit www.adherehealth.com.

Media Contact: 
Andrea LePain
eMedia Junction
andrea@emediajunction.com

617-275-8112

pills in a senior's hands

Overcoming 3 Key Challenges of Medication Adherence for High-Risk Members

For many Americans, taking prescription drugs is a routine – and essential – part of daily life and well-being. In

Compliance Packaging Is Key for Improving High-risk Patient Medication Adherence

Medication adherence is crucial for managing chronic diseases, especially in complex, high-risk patients. Compliance packaging is a key tool for

New CEO Strategies: How Chief Executives Coming Into A Company Can Find Opportunity

By Jason Rose, CEO of AdhereHealth Originally published in Forbes Business Council When an organization gets a new leader from

AdhereHealth’s Digital Pharmacy Launches New Compliance Packaging Solution for Underserved, Higher Risk Patients

AdhereRx “AdherePacks” improve value-based outcomes for higher risk Medicare Advantage and Medicaid patients by simplifying complex drug routines and fostering

AdhereHealth Releases Next-Generation Resolve Offering to Improve Member Experience for CAHPS and HOS Surveys

New Adhere™ Platform capabilities support dramatic CMS Increase of Medicare Advantage CAHPS Member Experience Star Rating Weighting to 32% through

Postdischarge Medication Reconciliation Is the Key to Reducing Hospital Readmissions

Medicare Advantage plans have a clear opportunity to improve quality by delivering more comprehensive, timely medication reconciliation services to recently

AdhereHealth Launches High-Risk Patient COVID-19 Vaccine Accelerator for the Underserved

Innovative solution leverages analytics and outbound tele-pharmacy to ensure equitable access to vaccinations by engaging vulnerable populations and reducing barriers

Medically Necessary: Making the vaccine supply chain work for communities of color

Americans of color are receiving the vaccine at far lower rates than white Americans, even though people of color are

Building a Comprehensive Strategy for Medicare Advantage Star Ratings

Whether you are a health plan leader or financial executive, you’re well aware that achieving and maintaining excellent Medicare Advantage

Medication Adherence Is Key To Addressing the Social Determinants of Health During the COVID-19 Pandemic

More than a year after scientists identified the first cases of COVID-19, infection rates continue to rise in regions across

It’s the Zip Code, Not the Genetic Code—The Need for an Equitable Vaccination Strategy

There is an urgent need to accelerate vaccination distribution for vulnerable Americans by overcoming problems involving social determinants of health.

CMS 2022 Final Rules: Top 6 Things Health Plans Should Know

CMS has finalized a series of policy and technical changes to Medicare Advantage (MA) and the Medicare Prescription Drug Benefit